A carregar...
RAAS inhibitors do not increase the risk of COVID-19
According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in...
Na minha lista:
| Publicado no: | Nat Rev Cardiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243952/ https://ncbi.nlm.nih.gov/pubmed/32444693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41569-020-0401-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|